Healthcare Tracked since Q3 FY26 - Q3 FY26

Torrent Pharmaceuticals Ltd

TORRENTPHARMACEUTICALS

Latest quarter Q3 FY26

Revenue ₹3,333 Cr (+18% YoY)

Management credibility Building

Needs more scored promises across 1 quarters

Latest signal bullish

Torrent Pharma delivered a strong Q3 FY26 with 18% revenue growth to ₹3,333 crore and 19% EBITDA growth to ₹1,088 cro...

Quarterly Earnings Timeline

Filing-verified financials, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q3 FY26 10 Feb 2026

bullish high

Revenue ₹3,333 Cr (+18% YoY)

Torrent Pharma delivered a strong Q3 FY26 with 18% revenue growth to ₹3,333 crore and 19% EBITDA growth to ₹1,088 crore, driven by double-digit expansion in India (+14...

Scorecard starts after historical backfill Read full analysis →